MONOPHARMA (MONOPHARMA) fundamentals
MONOPHARMA is a listed company, part of the Trading sector, listed on the NSE as MONOPHARMA (ISIN INE0OIP01012). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What MONOPHARMA does
Mono Pharmacare Limited is an India-based pharmaceutical company. The Company is engaged in the business of distribution of pharmaceutical items. The Company offers health care products, such as antibiotic, cough cold anti allergic, antifungal, nutraceutical, analgesic and antipyretic, antacid and antiemetic, cardiac diabetic, skincare, antiseptic, bronchodilators, pro-biotic, and antihistamines. It is offering services to retailers all over Ahmedabad and its peripheries with 5000+ products.
Valuation and market data
| Last close | ₹8.95 |
|---|---|
| Market capitalisation | ₹16 crore |
| Enterprise value | ₹41 crore |
| P/E (TTM) | 0.00 |
| Price to book | 0.51 |
| Price to sales (TTM) | 0.00 |
| Book value per share | ₹17.57 |
| Dividend yield | 0.00% |
| Sector | Trading |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹93 crore | ₹0 crore | ₹0 crore | 0.00 |
| Mar 2025 | ₹85 crore | ₹4 crore | ₹3 crore | 1.75 |
| Mar 2024 | ₹72 crore | ₹3 crore | ₹2 crore | 1.59 |
| Mar 2023 | ₹14 crore | ₹1 crore | ₹1 crore | 0.55 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 56.7% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 43.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.